These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 33127550)
1. Effect of O-glycosylation on amyloid fibril formation of the variable domain in the Vλ6 light chain mutant Wil. Abe Y; Shibata H; Oyama K; Ueda T Int J Biol Macromol; 2021 Jan; 166():342-351. PubMed ID: 33127550 [TBL] [Abstract][Full Text] [Related]
2. Compound screening identified gossypetin and isoquercitrin as novel inhibitors for amyloid fibril formations of Vλ6 proteins associated with AL amyloidosis. Takahashi D; Matsunaga E; Yamashita T; Caaveiro JMM; Abe Y; Ueda T Biochem Biophys Res Commun; 2022 Mar; 596():22-28. PubMed ID: 35108650 [TBL] [Abstract][Full Text] [Related]
3. Structural basis of light chain amyloidogenicity: comparison of the thermodynamic properties, fibrillogenic potential and tertiary structural features of four Vlambda6 proteins. Wall JS; Gupta V; Wilkerson M; Schell M; Loris R; Adams P; Solomon A; Stevens F; Dealwis C J Mol Recognit; 2004; 17(4):323-31. PubMed ID: 15227639 [TBL] [Abstract][Full Text] [Related]
4. A single mutation at the sheet switch region results in conformational changes favoring lambda6 light-chain fibrillogenesis. Hernández-Santoyo A; del Pozo Yauner L; Fuentes-Silva D; Ortiz E; Rudiño-Piñera E; Sánchez-López R; Horjales E; Becerril B; Rodríguez-Romero A J Mol Biol; 2010 Feb; 396(2):280-92. PubMed ID: 19941869 [TBL] [Abstract][Full Text] [Related]
5. Residual structures in the acid-unfolded states of Vlambda6 proteins affect amyloid fibrillation. Mishima T; Ohkuri T; Monji A; Kanemaru T; Abe Y; Ueda T J Mol Biol; 2009 Oct; 392(4):1033-43. PubMed ID: 19647748 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of amyloid fibril formation in the variable domain of λ6 light chain mutant Wil caused by the interaction between its unfolded state and epigallocatechin-3-O-gallate. Abe Y; Odawara N; Aeimhirunkailas N; Shibata H; Fujisaki N; Tachibana H; Ueda T Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2570-2578. PubMed ID: 30251653 [TBL] [Abstract][Full Text] [Related]
7. Thermodynamic instability of human lambda 6 light chains: correlation with fibrillogenicity. Wall J; Schell M; Murphy C; Hrncic R; Stevens FJ; Solomon A Biochemistry; 1999 Oct; 38(42):14101-8. PubMed ID: 10529258 [TBL] [Abstract][Full Text] [Related]
8. Mechanism for retardation of amyloid fibril formation by sugars in Vλ6 protein. Abe M; Abe Y; Ohkuri T; Mishima T; Monji A; Kanba S; Ueda T Protein Sci; 2013 Apr; 22(4):467-74. PubMed ID: 23389799 [TBL] [Abstract][Full Text] [Related]
10. Heat-induced native dimerization prevents amyloid formation by variable domain from immunoglobulin light-chain REI. Nawata M; Tsutsumi H; Kobayashi Y; Unzai S; Mine S; Nakamura T; Uegaki K; Kamikubo H; Kataoka M; Hamada D FEBS J; 2017 Sep; 284(18):3114-3127. PubMed ID: 28736891 [TBL] [Abstract][Full Text] [Related]
11. Mutational and genetic determinants of λ6 light chain amyloidogenesis. González-Andrade M; Becerril-Luján B; Sánchez-López R; Ceceña-Álvarez H; Pérez-Carreón JI; Ortiz E; Fernández-Velasco DA; del Pozo-Yauner L FEBS J; 2013 Dec; 280(23):6173-83. PubMed ID: 24107228 [TBL] [Abstract][Full Text] [Related]
12. Prevention of amyloid fibril formation of amyloidogenic chicken cystatin by site-specific glycosylation in yeast. He J; Song Y; Ueyama N; Saito A; Azakami H; Kato A Protein Sci; 2006 Feb; 15(2):213-22. PubMed ID: 16434741 [TBL] [Abstract][Full Text] [Related]
13. Counteracting effects of renal solutes on amyloid fibril formation by immunoglobulin light chains. Kim YS; Cape SP; Chi E; Raffen R; Wilkins-Stevens P; Stevens FJ; Manning MC; Randolph TW; Solomon A; Carpenter JF J Biol Chem; 2001 Jan; 276(2):1626-33. PubMed ID: 11050093 [TBL] [Abstract][Full Text] [Related]
14. Probing the role of λ6 immunoglobulin light chain dimerization in amyloid formation. Wolwertz ML; Nguyen PT; Quittot N; Bourgault S Biochim Biophys Acta; 2016 Apr; 1864(4):409-18. PubMed ID: 26802902 [TBL] [Abstract][Full Text] [Related]
15. Decreased amyloidogenicity caused by mutational modulation of surface properties of the immunoglobulin light chain BRE variable domain. Kobayashi Y; Tsutsumi H; Abe T; Ikeda K; Tashiro Y; Unzai S; Kamikubo H; Kataoka M; Hiroaki H; Hamada D Biochemistry; 2014 Aug; 53(31):5162-73. PubMed ID: 25062800 [TBL] [Abstract][Full Text] [Related]
16. Effects of His mutations on the fibrillation of amyloidogenic Vlambda6 protein Wil under acidic and physiological conditions. Mishima T; Ohkuri T; Monji A; Kanemaru T; Abe Y; Ueda T Biochem Biophys Res Commun; 2010 Jan; 391(1):615-20. PubMed ID: 19932684 [TBL] [Abstract][Full Text] [Related]
17. MAK33 antibody light chain amyloid fibrils are similar to oligomeric precursors. Hora M; Sarkar R; Morris V; Xue K; Prade E; Harding E; Buchner J; Reif B PLoS One; 2017; 12(7):e0181799. PubMed ID: 28746363 [TBL] [Abstract][Full Text] [Related]
18. Effects of oxidative post-translational modifications on structural stability and self-assembly of λ6 immunoglobulin light chain. Zottig X; Laporte Wolwertz M; Golizeh M; Ohlund L; Sleno L; Bourgault S Biophys Chem; 2016 Dec; 219():59-68. PubMed ID: 27744229 [TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin light chain amyloid aggregation. Blancas-Mejia LM; Misra P; Dick CJ; Cooper SA; Redhage KR; Bergman MR; Jordan TL; Maar K; Ramirez-Alvarado M Chem Commun (Camb); 2018 Sep; 54(76):10664-10674. PubMed ID: 30087961 [TBL] [Abstract][Full Text] [Related]
20. Mutations can cause light chains to be too stable or too unstable to form amyloid fibrils. Marin-Argany M; Güell-Bosch J; Blancas-Mejía LM; Villegas S; Ramirez-Alvarado M Protein Sci; 2015 Nov; 24(11):1829-40. PubMed ID: 26300552 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]